" /> Ruthenium-based Transferrin Targeting Agent NKP-1339 - CISMeF





Preferred Label : Ruthenium-based Transferrin Targeting Agent NKP-1339;

NCIt related terms : IT-139;

NCIt definition : A ruthenium-containing cancer agent targeting transferrin with potential antineoplastic activity. Upon intravenous administration, NKP-1339 (Ru3 ) binds to transferrin (Tf) and is taken up via Tf receptors (TfR), which are overexpressed on cancer cells. Once inside the cell, NKP-1339 is released from Tf and is reduced, within the acidic environment of the endosomes, to its active form NKP-119 (Ru2 ). In turn, the active form induces a redox reaction, thereby leading to the formation of reactive oxygen species (ROS) which inhibits GRP78 and SOD, endoplasmic reticulum-stress modulating molecules as well as BAG4 and ERK, program cell death regulating molecules. This eventually induces caspase-dependent apoptosis.;

UNII : 7OSJ9KS483;

CAS number : 197723-00-5;

Molecule name : NKP-1339;

Détails


Vous pouvez consulter :


Nous contacter.
24/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.